Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 1,061,931	$ (11,255)
Adjustments to reconcile net income (loss) to net cash Used in operating activities:
Interest earned on marketable securities held in trust account	(1,307,724)	(77,587)
Unrealized gain on marketable securities held in trust account	(241,602)	(83,323)
Amortization	57,183	36,575
Net changes in operating assets & liabilities:
Deferred offering costs		236,522
Prepaid expenses	(58,125)	(150,000)
Accrued offering costs		(31,550)
Accrued expenses	143,996	59,015
Net cash used in operating activities	(344,341)	(21,603)
Cash flows from investing activities:
Investment of cash in trust account	(1,319,142)	(115,000,000)
Cash withdrawn from trust account to redeem public shares	60,089,158
Net cash provided by (used in) investing activities	58,770,016	(115,000,000)
Cash flows from financing activities:
Borrowings from related party	1,485,995
Proceeds from proceeds from sale of private placement units		3,300,000
Proceeds from Sale of Units		114,700,000
Payment of offering costs		(2,829,741)
Redemption of public shares	(60,089,158)
Net cash provided by (used in) financing activities	(58,603,163)	115,170,259
Net change in cash and cash equivalents	(177,488)	148,656
Cash and cash equivalents at beginning of period	178,652	95,978
Cash and cash equivalents at end of period	1,164	244,634
Supplemental disclosure of non-cash investing and financing activities:
Deferred underwriting compensation		2,875,000
Initial ordinary shares subject to possible redemption		101,200,000
Reclassification of offering costs related to public shares		(5,020,172)
Change in value of ordinary shares subject to redemption		18,820,172
Subsequent measurement of ordinary shares subject to redemption (interest earned, unrealized gain on trust account and additional funding for business combination extension)	$ 2,868,468	$ 160,910